Bristol-Myers Squibb Company (BMY) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

• Price: $61.09
• Market Cap: $124.84B
• P/E Ratio: 17.72
• EPS: $3.46
• Dividend Yield: 0.04%
• 52-Week High: $62.12
• 52-Week Low: $41.88

Market Sentiment

Bristol-Myers Squibb Company currently has a Bullish sentiment score of 0.16.

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company (BMY) is a prominent global biopharmaceutical leader headquartered in New York City, renowned for its innovation in the discovery and delivery of transformative medicines. With a strategic focus on key therapeutic areas such as oncology, cardiovascular disease, immunology, and hematology, the company boasts a diverse portfolio that includes several well-established, market-leading therapies. BMS's dedication to addressing significant unmet medical needs, coupled w...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Bristol-Myers Squibb Company and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is BMY's current dividend yield?

Bristol-Myers Squibb Company (BMY) has a current dividend yield of 0.04%.

Does BMY pay dividends?

Yes, Bristol-Myers Squibb Company pays dividends with a current yield of 0.04%.

What is BMY's P/E ratio?

Bristol-Myers Squibb Company has a price-to-earnings (P/E) ratio of 17.72.

What is BMY's market cap?

Bristol-Myers Squibb Company (BMY) has a market capitalization of $124.84B with a current stock price of $61.09.